PIMCO Canada Launches the PIMCO Low Duration Monthly Income

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
21
PIMCO Canada Launches the PIMCO Low Duration Monthly Income Fund for Canadian Investors

TORONTO, Feb. 08, 2019 (GLOBE NEWSWIRE) -- PIMCO Canada Corp. (“PIMCO Canada”) has launched the PIMCO Low Duration Monthly Income Fund (Canada), which is designed for investors who seek income with low interest rate exposure. The fund will be managed by Dan Ivascyn, Managing Director and Group Chief Investment Officer, Alfred Murata, Managing Director and Portfolio Manager, and Josh Anderson, Managing Director and Portfolio Manager. This portfolio management team manages the popular Monthly Income Fund (Canada), and Mr. Ivascyn and Mr. Murata manage a similar Low Duration strategy in the U.S.

An actively managed strategy that seeks to generate income, preserve capital, and lower interest rate risk, the PIMCO Low Duration Monthly Income Fund (Canada) utilizes a multi-sector approach, allowing it to seek out the best income-generating ideas in any market climate, targeting multiple sources of income and low interest rate exposure from a global opportunity set.

“The desire for income continues to be a key theme for investors and we are pleased to add this fund to our growing range of solutions,” said Stuart Graham, Managing Director and Head of PIMCO Canada. 

An ETF series of the PIMCO Low Duration Monthly Income Fund (Canada) will trade under the ticker PLDI on the TSX, in addition to the traditional mutual fund series offered by PIMCO Canada.  

About PIMCO 
PIMCO is one of the world’s premier fixed income investment managers. With our launch in 1971 in Newport Beach, California, PIMCO introduced investors to a total return approach to fixed income investing. In the 45+ years since, we have continued to bring innovation and expertise to our partnership with clients seeking the best investment solutions. Today we have offices across the globe and 2,150+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz S.E., a leading global diversified financial services provider.

No offering is being made by this material. Interested investors should obtain a copy of the prospectus, which is available from your Financial Advisor.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

Investing in the bond market is subject to risks, including market, interest rate, issuer, credit, inflation risk, and liquidity risk. The value of most bonds and bond strategies are impacted by changes in interest rates. Bonds and bond strategies with longer durations tend to be more sensitive and volatile than those with shorter durations; bond prices generally fall as interest rates rise, and the current low interest rate environment increases this risk. Current reductions in bond counterparty capacity may contribute to decreased market liquidity and increased price volatility. Bond investments may be worth more or less than the original cost when redeemed. Sovereign securities are generally backed by the issuing government. Obligations of U.S. government agencies and authorities are supported by varying degrees, but are generally not backed by the full faith of the U.S. government. Portfolios that invest in such securities are not guaranteed and will fluctuate in value. Investing in foreign-denominated and/or -domiciled securities may involve heightened risk due to currency fluctuations, and economic and political risks, which may be enhanced in emerging markets. Mortgage- and asset-backed securities may be sensitive to changes in interest rates, subject to early repayment risk, and while generally supported by a government, government-agency or private guarantor, there is no assurance that the guarantor will meet its obligations. Derivatives may involve certain costs and risks, such as liquidity, interest rate, market, credit, management and the risk that a position could not be closed when most advantageous. Investing in derivatives could lose more than the amount invested.

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions “expect”, “intend”, “will” and similar expressions to the extent they relate to the Funds.  The forward-looking statements are not historical facts but reflect the Fund’s, PIMCO Canada and/or PIMCO’s current expectations regarding future results or events.  These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including, but not limited to, market factors.  Although the Fund, PIMCO Canada and/or PIMCO believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein.  The Fund, PIMCO Canada and/or PIMCO undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other factors which affect this information, except as required by law.

This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world. ©2019, PIMCO

The products and services provided by PIMCO Canada Corp. may only be available in certain provinces or territories of Canada and only through dealers authorized for that purpose.

PIMCO Canada has retained PIMCO LLC as sub-adviser. PIMCO Canada will remain responsible for any loss that arises out of the failure of its sub-adviser.

PIMCO Canada Corp., 199 Bay Street, Suite 2050, Commerce Court Station, P.O. Box 363, Toronto, ON, M5L 1G2, 416-368-3350

CMR2019-0128-377984

Contact:
Agnes Crane
PIMCO – Media Relations
Ph. 212-597-1054
Email: agnes.crane@pimco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Shift at Tourmaline Bio: CMO Resignation Announced

Updated Category News Views 119

Leadership Transition at Tourmaline Bio Tourmaline Bio, Inc. (NASDAQ:TRML) has recently revealed a significant change within its leadership. Dr. Yung Chyung, the Chief Medical Officer (CMO), is set to resign from his post effective at the end of October. This announcement took place in a recent filing, highlighting the company's commitment to transparency as it reshapes...

Continue Reading
Innovative Cancer Research by Compugen at Upcoming Conference

Updated Category News Views 118

Compugen to Showcase Groundbreaking Research in Cancer Immunotherapy Compugen Ltd. (Nasdaq: CGEN), a leading force in clinical-stage cancer immunotherapy, has announced an exciting opportunity to present at the upcoming Single Cell Genomics 2025 Conference. This event, scheduled for September 15-17, highlights advancements in genomics and how it intertwines with cancer...

Continue Reading
Transform Your Finances: The Journey of Salesforce Stock

Updated Category News Views 222

Transformational Growth of Salesforce Stock Over the past 15 years, Salesforce (NYSE: CRM) has emerged as a powerhouse in the tech industry, consistently surpassing market expectations. With an impressive average annual return rate of 22.25%, it has outperformed the broader market by 10.15% on an annualized basis. As of now, the company's market capitalization stands at...

Continue Reading
Infosys and AGCO Join Forces for Transformational Success

Updated Category News Views 185

Infosys and AGCO Team Up for IT and HR Transformation Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz. Infosys (NSE: INFY), a global leader in next-generation digital services and consulting, has announced the continuation of its strategic partnership with AGCO Corporation (NYSE:...

Continue Reading
Transforming Europe's Contract Furniture Market with AI Strategies

Updated Category News Views 385

Growth of Europe's Contract Furniture Market The contract furniture and furnishing market in Europe is on the verge of a substantial transformation, anticipating an impressive growth of USD 4.75 billion from 2024 to 2028. The compound annual growth rate (CAGR) is expected to be close to 5.1% during this forecast period. This expansion is mainly driven by the increasing...

Continue Reading